VEJA TAMBÉM
NFAT Anticorpos
Empty Table Header | Nome do Produto | CATALOG # | Isótopo | Epitopo | Aplicacao | Species | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|---|
NFAT5 Anticorpo (F-9) | sc-398171 | mouse IgG2a κ | 67-300 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 17 | ||
NFAT5 Anticorpo (37X) | sc-101098 | mouse IgG1 | 1422-1532 (h) | WB, IP, ELISA | h | 2 | ||
NFATc1 Anticorpo (7A6) | sc-7294 | mouse IgG1 κ | 197-304 (h) | WB, IP, IF, IHC(P), FCM | m, r, h | 632 | ||
NFATc1 Anticorpo (H-10) | sc-17834 | mouse IgG1 κ | 1-110 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 18 | ||
NFATc2 Anticorpo (4G6-G5) | sc-7296 | mouse IgG2a κ | 433-567 (m) | WB, IP, IHC(P) | m, r, h | 153 | ||
NFATc2 Anticorpo (A-2) | sc-514929 | mouse IgG1 κ | 191-410 (h) | WB, IP, IF, ELISA | m, r, h | 3 | ||
NFATc2 Anticorpo (G1-D10) | sc-7295 | mouse IgG2a κ | 433-567 (m) | IP, IF | m, r, h | 43 | ||
NFATc2 Anticorpo (1) | sc-136206 | mouse IgG1 | 29-181 (h) | WB, IP, IF | h and canine | 2 | ||
NFATc3 Anticorpo (F-1) | sc-8405 | mouse IgG1 κ | 321-395 (m) | WB, IP, IF, IHC(P), ELISA | m, r, h | 100 | ||
NFATc4 Anticorpo (B-2) | sc-271597 | mouse IgG2a κ | 125-198 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 12 | ||
NFATc4 Anticorpo (A-2) | sc-271127 | mouse IgG2b κ | 125-198 (h) | WB, IP, IF, ELISA | h | 3 | ||
NFATc4 Anticorpo (F-3) | sc-271091 | mouse IgG2b κ | 125-198 (h) | WB, IP, IF, ELISA | h | 1 | ||
NFATc4 Anticorpo (F-4) | sc-515584 | mouse IgM κ | 877-902 (h) | WB, IP, IF, ELISA | m, r, h | new |
Anticorpos Fosfo-Especificos
Empty Table Header | Nome do Produto | CATALOG # | Isótopo | Epitopo | Aplicacao | Species | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|---|
p-NFATc3 Anticorpo (C-3) | sc-365786 | mouse IgG1 κ | Ser 240 (h) | WB, IP, IF, ELISA | m, r, h | 4 | ||
p-NFATc3 Anticorpo (A-1) | sc-365785 | mouse IgG1 κ | Ser 172 (h) | WB, IP, IF, ELISA | m, r, h | 3 | ||
p-NFATc3 Anticorpo (H-2) | sc-365883 | mouse IgG2b κ | Ser 169 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
p-NFATc4 Anticorpo (80.S168/170) | sc-135771 | mouse IgG2a κ | Ser 168/170 (h) | WB, IP, ELISA | m, r, h | 4 |
NFAT CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|
NFATc1 Plasmídeo CRISPR/Cas9 KO (h) | sc-400164 | h | Gene Knockout | GFP | 0 | ||
NFATc1 Plasmídeo CRISPR/Cas9 KO (h2) | sc-400164-KO-2 | h | Gene Knockout | GFP | 0 | ||
NFATc1Plasmídeo HDR (h2) | sc-400164-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
NFATc1 Plasmídeo duplo de Nickase (h) | sc-400164-NIC | h | Gene Knockout | Puromycin | 0 | ||
NFATc1 Plasmídeo duplo de Nickase (h2) | sc-400164-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NFATc1 Plasmídeo CRISPR/Cas9 KO (m) | sc-421863 | m | Gene Knockout | GFP | 0 | ||
NFATc1Plasmídeo HDR (m) | sc-421863-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NFATc1 Plasmídeo duplo de Nickase (m) | sc-421863-NIC | m | Gene Knockout | Puromycin | 0 | ||
NFATc1 Plasmídeo duplo de Nickase (m2) | sc-421863-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
NFATc2 Plasmídeo CRISPR/Cas9 KO (h) | sc-400422 | h | Gene Knockout | GFP | 0 | ||
NFATc2 Plasmídeo duplo de Nickase (h) | sc-400422-NIC | h | Gene Knockout | Puromycin | 0 | ||
NFATc2 Plasmídeo duplo de Nickase (h2) | sc-400422-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NFATc2 Plasmídeo CRISPR/Cas9 KO (m) | sc-421864 | m | Gene Knockout | GFP | 0 | ||
NFATc2Plasmídeo HDR (m) | sc-421864-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NFATc2 Plasmídeo duplo de Nickase (m) | sc-421864-NIC | m | Gene Knockout | Puromycin | 0 | ||
NFATc2 Plasmídeo duplo de Nickase (m2) | sc-421864-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
NFATc3 Plasmídeo CRISPR/Cas9 KO (h) | sc-400339 | h | Gene Knockout | GFP | 0 | ||
NFATc3Plasmídeo HDR (h) | sc-400339-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
NFATc3 Plasmídeo duplo de Nickase (h) | sc-400339-NIC | h | Gene Knockout | Puromycin | 0 | ||
NFATc3 Plasmídeo duplo de Nickase (h2) | sc-400339-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NFATc3 Plasmídeo CRISPR/Cas9 KO (m) | sc-421866 | m | Gene Knockout | GFP | 0 | ||
NFATc3Plasmídeo HDR (m) | sc-421866-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NFATc3 Plasmídeo duplo de Nickase (m) | sc-421866-NIC | m | Gene Knockout | Puromycin | 0 | ||
NFATc3 Plasmídeo duplo de Nickase (m2) | sc-421866-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
NFATc4 Plasmídeo CRISPR/Cas9 KO (h) | sc-417766 | h | Gene Knockout | GFP | 0 | ||
NFATc4Plasmídeo HDR (h) | sc-417766-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
NFATc4 Plasmídeo duplo de Nickase (h) | sc-417766-NIC | h | Gene Knockout | Puromycin | 0 | ||
NFATc4 Plasmídeo duplo de Nickase (h2) | sc-417766-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NFATc4 Plasmídeo CRISPR/Cas9 KO (m) | sc-428517 | m | Gene Knockout | GFP | 0 | ||
NFATc4Plasmídeo HDR (m) | sc-428517-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NFATc4 Plasmídeo duplo de Nickase (m) | sc-428517-NIC | m | Gene Knockout | Puromycin | 0 | ||
NFATc4 Plasmídeo duplo de Nickase (m2) | sc-428517-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
NFAT5 Plasmídeo CRISPR/Cas9 KO (h) | sc-401359 | h | Gene Knockout | GFP | 0 | ||
NFAT5 Plasmídeo duplo de Nickase (h) | sc-401359-NIC | h | Gene Knockout | Puromycin | 0 | ||
NFAT5 Plasmídeo duplo de Nickase (h2) | sc-401359-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NFAT5 Plasmídeo CRISPR/Cas9 KO (m) | sc-424873 | m | Gene Knockout | GFP | 0 | ||
NFAT5Plasmídeo HDR (m) | sc-424873-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NFAT5 Plasmídeo duplo de Nickase (m) | sc-424873-NIC | m | Gene Knockout | Puromycin | 0 | ||
NFAT5 Plasmídeo duplo de Nickase (m2) | sc-424873-NIC-2 | m | Gene Knockout | Puromycin | 0 |
NFAT CRISPR Activation Products
NFAT siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|
NFATc1 siRNA (h) | sc-29412 | h | Gene Silencing | N/A | 10 | ||
NFATc1 siRNA (h2) | sc-156125 | h | Gene Silencing | N/A | 1 | ||
NFATc1 Plasmídeo shRNA (h) | sc-29412-SH | h | Gene Silencing | Puromycin | 10 | ||
NFATc1 sarna (h) Partículas de lentivirus | sc-29412-V | h | Gene Silencing | Puromycin | 10 | ||
NFATc1 sarna (h2) Partículas de lentivirus | sc-156125-V | h | Gene Silencing | Puromycin | 1 | ||
NFATc1 siRNA (m) | sc-36054 | m | Gene Silencing | N/A | 5 | ||
NFATc1 Plasmídeo shRNA (m) | sc-36054-SH | m | Gene Silencing | Puromycin | 5 | ||
NFATc1 sarna (m) Partículas de lentivirus | sc-36054-V | m | Gene Silencing | Puromycin | 5 | ||
NFATc1 siRNA (r) | sc-77366 | r | Gene Silencing | N/A | 1 | ||
NFATc1 Plasmídeo shRNA (r) | sc-77366-SH | r | Gene Silencing | Puromycin | 1 | ||
NFATc1 sarna (r) Partículas de lentivirus | sc-77366-V | r | Gene Silencing | Puromycin | 1 | ||
NFATc1 shRNA Plasmídeo shRNA (h2) | sc-156125-SH | h | Gene Silencing | Puromycin | 1 | ||
NFATc2 siRNA (h) | sc-36055 | h | Gene Silencing | N/A | 7 | ||
NFATc2 Plasmídeo shRNA (h) | sc-36055-SH | h | Gene Silencing | Puromycin | 7 | ||
NFATc2 sarna (h) Partículas de lentivirus | sc-36055-V | h | Gene Silencing | Puromycin | 7 | ||
NFATc2 siRNA (m) | sc-36056 | m | Gene Silencing | N/A | 2 | ||
NFATc2 Plasmídeo shRNA (m) | sc-36056-SH | m | Gene Silencing | Puromycin | 2 | ||
NFATc2 sarna (m) Partículas de lentivirus | sc-36056-V | m | Gene Silencing | Puromycin | 2 | ||
NFATc3 siRNA (h) | sc-29413 | h | Gene Silencing | N/A | 2 | ||
NFATc3 Plasmídeo shRNA (h) | sc-29413-SH | h | Gene Silencing | Puromycin | 2 | ||
NFATc3 sarna (h) Partículas de lentivirus | sc-29413-V | h | Gene Silencing | Puromycin | 2 | ||
NFATc3 siRNA (m) | sc-36057 | m | Gene Silencing | N/A | 0 | ||
NFATc3 Plasmídeo shRNA (m) | sc-36057-SH | m | Gene Silencing | Puromycin | 0 | ||
NFATc3 sarna (m) Partículas de lentivirus | sc-36057-V | m | Gene Silencing | Puromycin | 0 | ||
NFATc4 siRNA (h) | sc-38115 | h | Gene Silencing | N/A | 2 | ||
NFATc4 Plasmídeo shRNA (h) | sc-38115-SH | h | Gene Silencing | Puromycin | 2 | ||
NFATc4 sarna (h) Partículas de lentivirus | sc-38115-V | h | Gene Silencing | Puromycin | 2 | ||
NFATc4 siRNA (m) | sc-38116 | m | Gene Silencing | N/A | 1 | ||
NFATc4 Plasmídeo shRNA (m) | sc-38116-SH | m | Gene Silencing | Puromycin | 1 | ||
NFATc4 sarna (m) Partículas de lentivirus | sc-38116-V | m | Gene Silencing | Puromycin | 1 | ||
NFAT5 siRNA (h) | sc-43968 | h | Gene Silencing | N/A | 20 | ||
NFAT5 Plasmídeo shRNA (h) | sc-43968-SH | h | Gene Silencing | Puromycin | 20 | ||
NFAT5 sarna (h) Partículas de lentivirus | sc-43968-V | h | Gene Silencing | Puromycin | 20 | ||
NFAT5 siRNA (m) | sc-38122 | m | Gene Silencing | N/A | 4 | ||
NFAT5c Plasmídeo shRNA (m) | sc-38122-SH | m | Gene Silencing | Puromycin | 4 | ||
NFAT5c sarna (m) Partículas de lentivirus | sc-38122-V | m | Gene Silencing | Puromycin | 4 |
NFAT Oligonucleotides
Empty Table Header | Nome do Produto | CONSENSO CAT. # | MUTANTE CAT. # | Consenso MUTANTE | Motivo de ligação | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|
NFATc consensus oligonucleotide | sc-2577 | sc-2578 | 5’-CGC CCA AAG AGG AAA ATT TGT TTC ATA-3’ | "AGG"→"CTT" | 49 |